Shruthi Narayan: STORM-PE and STRIKE-PE Studies Advance Understanding of Recovery After Pulmonary Embolism
Shruthi Narayan, President at Penumbra, shared a post on LinkedIn:
”It has been an incredible October for PE research starting with the PERT Consortium Annual Symposium in Boston and continuing at the VIVA and VEINS conferences in Las Vegas. In Las Vegas we presented new findings from both the STORM-PE RCT and the STRIKE-PE study that help advance our understanding of what meaningful recovery looks like for PE patients.
STORM-PE became the FIRST RCT in PE to incorporate consumer wearable-derived data, demonstrating a significant correlation between clinically assessed exercise capacity and real-world activity captured during patients’ daily lives. These findings support the feasibility and clinical utility of wearables as a complementary measure of functional recovery after PE.
These findings build upon previously reported STORM-PE results, which showed that patients treated with CAVT plus anticoagulation experienced greater improvement in right ventricular recovery and functional outcomes compared with anticoagulation alone.
Meanwhile, the latest STRIKE-PE analysis adds important scale to the evidence base. With 1,000 prospective patients, it represents one of the largest prospective evaluations of functional recovery and quality of life following PE treatment. The results showed that exercise capacity, shortness of breath, and quality-of-life measures among patients treated with CAVT improved significantly in the first 90 days and either continued to improve or were sustained through one year.
Together, these studies provide a more complete picture of recovery after CAVT. They also show that innovation in PE care isn’t only about new technologies. It’s also about developing better ways to understand recovery and the outcomes that matter most to patients.
Thank you to the investigators and patients who made this research possible.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 18:12Adil Nawaz: Extended Dual Antiplatelet Therapy After Coronary Stenting
-
Oct 16, 2026, 17:50Elad AsherÖ‰ STORM-PE Shows Functional Benefits of Thrombectomy
-
Oct 16, 2026, 17:22Wolfgang MiesbachÖ‰ What a Near-Perfect FISH Score Fails to See
-
Oct 16, 2026, 17:06Troels Wienecke: Connecting Myeloproliferative Disease and Ischemic Stroke
-
Oct 16, 2026, 17:03Only 5 Days Left to Submit Your Research for EAHAD 2027
-
Oct 16, 2026, 16:48Abdul Rahman: Reticulocyte Count and Bone Marrow Activity
-
Oct 16, 2026, 16:44DOAC Adherence in Stroke Patients With Atrial Fibrillation – International Journal of Stroke
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards